Orexo US Inc.
Parsippany-Troy Hills, NJ
- UEI
- MN1MPMBCVVD5
- CAGE
- 6Y7L3
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Orexo AB, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1 Gatehall Dr #309, Parsippany, NJ 07054, USA
- Website
- orexo.com
- Founded
- 1995
- Employees
- 51-250
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $2,999,997 |
| FY2025 | $8,450,715 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $2,999,997 |
Contract vehicles
Contract awards
Quick answers
Is Orexo US Inc. registered in SAM.gov?
Yes. Orexo US Inc.'s SAM.gov registration is active through October 23, 2027.
What is Orexo US Inc.'s CAGE code?
Orexo US Inc.'s CAGE code is 6Y7L3, and its Unique Entity ID (UEI) is MN1MPMBCVVD5.
Which contract vehicles does Orexo US Inc. hold?
Orexo US Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Orexo US Inc. received in federal contracts?
Federal contracts obligated $8,450,715 to Orexo US Inc. in fiscal year 2025 and $11,450,712 in fiscal years 2023 through 2027.
How does Orexo US Inc. rank among federal contractors?
Orexo US Inc.'s parent company, Orexo AB, ranked #37 in PSC AN13, #46 in NAICS 541714 and #99 in PSC AN in FY2025.
What is Orexo US Inc.'s most recent federal award?
Orexo US Inc.'s most recent federal contract award is Clinical development of OX390 (ATIPAMEZOLE) as an ?2 agonist reversal agent for human use to counteract the sedative… (75A50125C00010), from Office of the Assistant Secretary for Preparedness and Response, on September 24, 2025.
On GovTribe
See Orexo US Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors